Pulmonology
Fenoterol PSK
Registration certificate:
INN:
Fenoterol
Release form:
Solution for inhalation
Therapeutic Area:
Pulmonology
Pharmacotherapeutic Group:
Bronchodilator – selective β2-adrenergic agonist
Conditions for dispensing:
On prescription
Packaging:

Indications for use: 

  • Treatment of bronchial asthma attacks or other conditions with reversible airway obstruction (including chronic bronchitis, chronic obstructive pulmonary disease) 
  • Prevention of bronchial asthma attacks due to physical exertion 
  • As a bronchodilator before inhalation of other medications (antibiotics, mucolytics, glucocorticosteroids) 
  • Conducting bronchodilation tests during pulmonary function testing 

This product is not included in the Essential Drug List (EDL).

Regulatory Status: Rx only

THERE ARE CONTRAINDICATIONS AND DRUG INTERACTIONS. PLEASE CONSULT A SPECIALIST BEFORE USE.

For the full version of the Fenoterol PSK (Fenoterol) leaflet, please visit the official website: https://grls.rosminzdrav.ru/Default.aspx

Quality control
at all stages of production